Phathom Pharmaceuticals

Phathom Pharmaceuticals

  • Founded: 2019
  • Location: Menlo Park, CA
  • Employee range: 50 - 200
  • Clinical stage: COM
  • Therapy area: H. pylori infection
  • Drug types: INF, GI, PED
  • Lead product: Voquezna (Vonoprazan) 
  • Product link:
  • Funding: $150M stock May 2023; $182M IPO Oct 2019; $90M May 2019
  • Investors: Frazier Healthcare Partners, Medicxi, RA Capital Management, Abingworth

job board

Short description:

Novel treatments for gastrointestinal diseases and disorders

Drug notes:

Also NDA errosive GERD, heartburn, Clin3 heartburn in non-erosive GERD, different dosing Clin2 heartburn in non-erosive GERD, Clin2 eosinophilic esophagitis

Long description:

Contact us to add description.


© 2023 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy